A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Patients With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation - Regional Cancer Care Associates LLC

Clinical Trials

A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Patients With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation

Type of Cancer
Multiple Myeloma
Locations
East Brunswick
Freehold
Howell
Little Silver
Sponsor
MILLENIUM
Protocol Number
C16021
Cancer Diagnosis
To Learn More Call
201-510-0910